BeyondSpring Inc. (NASDAQ:BYSI – Get Free Report)’s share price traded up 0.6% during trading on Wednesday . The stock traded as high as $1.73 and last traded at $1.71. 7,301 shares traded hands during trading, a decline of 45% from the average session volume of 13,166 shares. The stock had previously closed at $1.70.
BeyondSpring Stock Performance
The firm has a 50 day moving average of $1.68 and a 200 day moving average of $1.91.
BeyondSpring Company Profile
BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia.
See Also
- Five stocks we like better than BeyondSpring
- Short Selling – The Pros and Cons
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- What is diluted earnings per share (Diluted EPS)?
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- Options Trading – Understanding Strike Price
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for BeyondSpring Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondSpring and related companies with MarketBeat.com's FREE daily email newsletter.
